BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawabata A, Matsunami M, Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol. 2008;153 Suppl 1:S230-S240. [PMID: 17994114 DOI: 10.1038/sj.bjp.0707491] [Cited by in Crossref: 56] [Cited by in F6Publishing: 67] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Reches G, Blondheim Shraga NR, Carrette F, Malka A, Saleev N, Gubbay Y, Ertracht O, Haviv I, Bradley LM, Levine F, Piran R. Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries. Inflamm Regen 2022;42:52. [PMID: 36447218 DOI: 10.1186/s41232-022-00238-2] [Reference Citation Analysis]
2 Korot’ko GF. Recirculation and adaptation secrete enzymes of digestive glands. jour 2022. [DOI: 10.31146/1682-8658-ecg-200-4-138-152] [Reference Citation Analysis]
3 Mirakhur M, Diener M. Proteinase-activated receptors regulate intestinal functions in a segment-dependent manner in rats. Eur J Pharmacol 2022;933:175264. [PMID: 36100127 DOI: 10.1016/j.ejphar.2022.175264] [Reference Citation Analysis]
4 Suhaj P, Olejar T, Matej R. PAR2: The Cornerstone of Pancreatic Diseases. Physiol Res 2022;71:583-96. [PMID: 36073735 DOI: 10.33549/physiolres.934931] [Reference Citation Analysis]
5 Puvača N, Tufarelli V, Giannenas I. Essential Oils in Broiler Chicken Production, Immunity and Meat Quality: Review of Thymus vulgaris, Origanum vulgare, and Rosmarinus officinalis. Agriculture 2022;12:874. [DOI: 10.3390/agriculture12060874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kim Y, Lee Y, Heo G, Jeong S, Park S, Yoo J, Jung Y, Im E. Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy. Cells 2022;11:878. [DOI: 10.3390/cells11050878] [Reference Citation Analysis]
7 Miranda A. Visceral Sensitivity. Pediatric Neurogastroenterology 2022. [DOI: 10.1007/978-3-031-15229-0_4] [Reference Citation Analysis]
8 Li YJ, Ao JP, Huang X, Lu HL, Fu HY, Song NN, Xu WX, Chen J. Involvement of PAR2 in platelet-derived growth factor receptor-α-positive cell proliferation in the colon of diabetic mice. Physiol Rep 2021;9:e15099. [PMID: 34755491 DOI: 10.14814/phy2.15099] [Reference Citation Analysis]
9 Bandara M, MacNaughton WK. Protease-activated receptor-2 activation enhances epithelial wound healing via epidermal growth factor receptor. Tissue Barriers 2021;:1968763. [PMID: 34511032 DOI: 10.1080/21688370.2021.1968763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Oliveira KA, Torquato RJS, Lustosa DCGG, Ribeiro T, Nascimento BWL, de Oliveira LCG, Juliano MA, Paschoalin T, Lemos VS, Araujo RN, Pereira MH, Tanaka AS. Proteolytic activity of Triatoma infestans saliva associated with PAR-2 activation and vasodilation. J Venom Anim Toxins Incl Trop Dis 2021;27:e20200098. [PMID: 33747067 DOI: 10.1590/1678-9199-JVATITD-2020-0098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lambertini C, Zannoni A, Romagnoli N, Bombardi C, Morini M, Dondi F, Bernardini C, Forni M, Rinnovati R, Spadari A. Expression of Proteinase-Activated Receptor 2 During Colon Volvulus in the Horse. Front Vet Sci 2020;7:589367. [PMID: 33330716 DOI: 10.3389/fvets.2020.589367] [Reference Citation Analysis]
12 Kikuchi K, Hamaue N, Machida T, Iizuka K, Minami M, Hirafuji M. Effects of nafamostat mesilate on 5-hydroxytryptamine release from isolated ileal tissues induced by anti-cancer drugs in rats. Biomed Res 2020;41:253-7. [PMID: 33071261 DOI: 10.2220/biomedres.41.253] [Reference Citation Analysis]
13 Kriaa A, Jablaoui A, Mkaouar H, Akermi N, Maguin E, Rhimi M. Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation. FASEB J 2020;34:7270-82. [PMID: 32307770 DOI: 10.1096/fj.202000031RR] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
14 Pontarollo G, Mann A, Brandão I, Malinarich F, Schöpf M, Reinhardt C. Protease-activated receptor signaling in intestinal permeability regulation. FEBS J 2020;287:645-58. [PMID: 31495063 DOI: 10.1111/febs.15055] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
15 Sung TS, Lu H, Sung J, Yeom JH, Perrino BA, Koh SD. The functional role of protease-activated receptors on contractile responses by activation of Ca(2+) sensitization pathways in simian colonic muscles. Am J Physiol Gastrointest Liver Physiol 2018;315:G921-31. [PMID: 30260688 DOI: 10.1152/ajpgi.00255.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Zhang Y, Ge T, Xiang P, Mao H, Tang S, Li A, Lin L, Wei Y. Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH2 on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism. Drug Des Devel Ther 2018;12:2403-11. [PMID: 30122898 DOI: 10.2147/DDDT.S160628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
17 Zeeh F, Witte D, Gädeken T, Rauch BH, Grage-Griebenow E, Leinung N, Fromm SJ, Stölting S, Mihara K, Kaufmann R, Settmacher U, Lehnert H, Hollenberg MD, Ungefroren H. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5. Oncotarget 2016;7:41095-109. [PMID: 27248167 DOI: 10.18632/oncotarget.9600] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
18 Sanchez LC. Disorders of the Gastrointestinal System. Equine Internal Medicine 2018. [DOI: 10.1016/b978-0-323-44329-6.00012-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
19 Tsubota M, Ozaki T, Hayashi Y, Okawa Y, Fujimura A, Sekiguchi F, Nishikawa H, Kawabata A. Prostanoid-dependent bladder pain caused by proteinase-activated receptor-2 activation in mice: Involvement of TRPV1 and T-type Ca2+ channels. J Pharmacol Sci 2018;136:46-9. [PMID: 29289470 DOI: 10.1016/j.jphs.2017.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Irie Y, Tsubota M, Ishikura H, Sekiguchi F, Terada Y, Tsujiuchi T, Liu K, Nishibori M, Kawabata A. Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis. J Neuroimmune Pharmacol 2017;12:693-707. [DOI: 10.1007/s11481-017-9757-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
21 Terada Y, Tsubota M, Sugo H, Wakitani K, Sekiguchi F, Wada K, Takada M, Oita A, Kawabata A. Tacrolimus Triggers Transient Receptor Potential Vanilloid-1-Dependent Relapse of Pancreatitis-Related Pain in Mice. Pharmacology 2017;99:281-5. [PMID: 28253495 DOI: 10.1159/000454816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Camilleri M, Halawi H, Oduyebo I. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we? Expert Rev Gastroenterol Hepatol 2017;11:303-16. [PMID: 28128666 DOI: 10.1080/17474124.2017.1288096] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
23 Witte D, Zeeh F, Gädeken T, Gieseler F, Rauch BH, Settmacher U, Kaufmann R, Lehnert H, Ungefroren H. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer. J Clin Med 2016;5:E111. [PMID: 27916875 DOI: 10.3390/jcm5120111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
24 Faure C, Righini Grunder F. Visceral Sensitivity. In: Faure C, Thapar N, Di Lorenzo C, editors. Pediatric Neurogastroenterology. Cham: Springer International Publishing; 2017. pp. 39-52. [DOI: 10.1007/978-3-319-43268-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Piran R, Lee SH, Kuss P, Hao E, Newlin R, Millán JL, Levine F. PAR2 regulates regeneration, transdifferentiation, and death. Cell Death Dis 2016;7:e2452. [PMID: 27809303 DOI: 10.1038/cddis.2016.357] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
26 Hayama T, Kamio N, Okabe T, Muromachi K, Matsushima K. Kallikrein Promotes Inflammation in Human Dental Pulp Cells Via Protease-Activated Receptor-1. J Cell Biochem 2016;117:1522-8. [PMID: 26566265 DOI: 10.1002/jcb.25437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
27 Akashi R. Significance of protease-activated receptor-2 in the development of post-ERCP pancreatitis. Journal of the Japan Pancreas Society 2015;30:783-795. [DOI: 10.2958/suizo.30.783] [Reference Citation Analysis]
28 Visceral Pain. Case Studies in Pain Management 2014. [DOI: 10.1017/cbo9781107281950.036] [Reference Citation Analysis]
29 Baruah A, Buttar N, Chandra R, Chen X, Clemons NJ, Compare D, El-rifai W, Gu J, Houchen CW, Koh SY, Li W, Nardone G, Phillips WA, Sharma A, Singh I, Upton MP, Vega KJ, Wu X. Translational research on Barrett's esophagus: Translational research on Barrett's esophagus. Ann N Y Acad Sci 2014;1325:170-86. [DOI: 10.1111/nyas.12531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
30 Zannoni A, Bombardi C, Dondi F, Morini M, Forni M, Chiocchetti R, Spadari A, Romagnoli N. Proteinase-activated receptor 2 expression in the intestinal tract of the horse. Res Vet Sci 2014;96:464-71. [PMID: 24656343 DOI: 10.1016/j.rvsc.2014.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Carroll IM, Maharshak N. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications. World J Gastroenterol 2013; 19(43): 7531-7543 [PMID: 24431894 DOI: 10.3748/wjg.v19.i43.7531] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
32 Gieseler F, Ungefroren H, Settmacher U, Hollenberg MD, Kaufmann R. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact. Cell Commun Signal 2013;11:86. [PMID: 24215724 DOI: 10.1186/1478-811X-11-86] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 12.9] [Reference Citation Analysis]
33 Yau MK, Liu L, Fairlie DP. Toward drugs for protease-activated receptor 2 (PAR2). J Med Chem 2013;56:7477-97. [PMID: 23895492 DOI: 10.1021/jm400638v] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
34 Sriwai W, Mahavadi S, Al-Shboul O, Grider JR, Murthy KS. Distinctive G Protein-Dependent Signaling by Protease-Activated Receptor 2 (PAR2) in Smooth Muscle: Feedback Inhibition of RhoA by cAMP-Independent PKA. PLoS One. 2013;8:e66743. [PMID: 23825105 DOI: 10.1371/journal.pone.0066743] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
35 Faure C. Visceral Sensitivity. Pediatric Neurogastroenterology 2013. [DOI: 10.1007/978-1-60761-709-9_4] [Reference Citation Analysis]
36 Huang S. Effects of trypsin, thrombin and proteinase-activated receptors on guinea pig common bile duct motility. Regulatory Peptides 2012;179:1-5. [DOI: 10.1016/j.regpep.2012.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Kugler EM, Mazzuoli G, Demir IE, Ceyhan GO, Zeller F, Schemann M. Activity of protease-activated receptors in primary cultured human myenteric neurons. Front Neurosci. 2012;6:133. [PMID: 22988431 DOI: 10.3389/fnins.2012.00133] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
38 Suen JY, Barry GD, Lohman RJ, Halili MA, Cotterell AJ, Le GT, Fairlie DP. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Br J Pharmacol 2012;165:1413-23. [PMID: 21806599 DOI: 10.1111/j.1476-5381.2011.01610.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 7.6] [Reference Citation Analysis]
39 Gu Q, Lee L. Protease-Activated Receptor 2. Therapeutic Targets 2012. [DOI: 10.1002/9781118185537.ch2] [Reference Citation Analysis]
40 Lohman RJ, Cotterell AJ, Barry GD, Liu L, Suen JY, Vesey DA, Fairlie DP. An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats. FASEB J. 2012;26:2877-2887. [PMID: 22467762 DOI: 10.1096/fj.11-201004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 7.0] [Reference Citation Analysis]
41 Yang CQ, Wei YY, Zhong CJ, Duan LP. Essential role of mast cells in the visceral hyperalgesia induced by T. spiralis infection and stress in rats. Mediators Inflamm. 2012;2012:294070. [PMID: 22529522 DOI: 10.1155/2012/294070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
42 Stoermer MJ, Flanagan B, Beyer RL, Madala PK, Fairlie DP. Structures of peptide agonists for human protease activated receptor 2. Bioorg Med Chem Lett 2012;22:916-9. [PMID: 22209488 DOI: 10.1016/j.bmcl.2011.12.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Puylaert M, Kapural L, Van Zundert J, Peek D, Lataster A, Mekhail N, van Kleef M, Keulemans YCA. Pain in Chronic Pancreatitis. Evidence‐Based Interventional Pain Medicine 2011. [DOI: 10.1002/9781119968375.ch26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Lohman RJ, Cotterell AJ, Suen J, Liu L, Do AT, Vesey DA, Fairlie DP. Antagonism of protease-activated receptor 2 protects against experimental colitis. J Pharmacol Exp Ther. 2012;340:256-265. [PMID: 22028393 DOI: 10.1124/jpet.111.187062] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
45 Rothmeier AS, Ruf W. Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol. 2012;34:133-149. [PMID: 21971685 DOI: 10.1007/s00281-011-0289-1] [Cited by in Crossref: 203] [Cited by in F6Publishing: 208] [Article Influence: 16.9] [Reference Citation Analysis]
46 Borrelli F, Capasso R, Severino B, Fiorino F, Aviello G, De Rosa G, Mazzella M, Romano B, Capasso F, Fasolino I, Izzo AA. Inhibitory effects of bromelain, a cysteine protease derived from pineapple stem (Ananas comosus), on intestinal motility in mice. Neurogastroenterol Motil 2011;23:745-e331. [PMID: 21689210 DOI: 10.1111/j.1365-2982.2011.01735.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
47 Sekiguchi F, Ohi A, Maeda Y, Takaoka K, Sekimoto T, Nishikawa H, Kawabata A. Delayed production of arachidonic acid contributes to the delay of proteinase-activated receptor-1 (PAR1)-triggered prostaglandin E2 release in rat gastric epithelial RGM1 cells. J Cell Biochem 2011;112:909-15. [PMID: 21328464 DOI: 10.1002/jcb.23005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
48 Zhang Y, Yu G, Wang Y, Xiang Y, Gao Q, Jiang P, Zhang J, Lee W, Zhang Y. Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2. Cell Mol Life Sci 2011;68:3771-80. [PMID: 21461878 DOI: 10.1007/s00018-011-0678-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
49 Lin YJ, Wang CD, Zhuang ZH, Fan H, Huang XR, Liu X. Treatment with nafamostat mesilate reduces mast cell number and down-regulates tryptase expression in experimental ulcerative colitis in rats. Shijie Huaren Xiaohua Zazhi 2011; 19(2): 126-131 [DOI: 10.11569/wcjd.v19.i2.126] [Reference Citation Analysis]
50 Lohman R, Jones NC, O’brien TJ, Cocks TM. A regulatory role for protease-activated receptor-2 in motivational learning in rats. Neurobiology of Learning and Memory 2009;92:301-9. [DOI: 10.1016/j.nlm.2009.03.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
51 Ikeda A, Gabazza EC, Morser J, Imoto I, Kuroda M, D'Alessandro-Gabazza CN, Hara K, Ruiz DB, Bernabe PG, Katsurahara M, Toda M, Kobayashi Y, Yano Y, Sumida Y, Suzuki K, Taguchi O, Takei Y. Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease. Helicobacter 2009;14:147-55. [PMID: 19298343 DOI: 10.1111/j.1523-5378.2009.00662.x] [Reference Citation Analysis]
52 Zhu A, Kaunitz J. Gastroduodenal mucosal defense. Curr Gastroenterol Rep 2008;10:548-54. [PMID: 19006609 DOI: 10.1007/s11894-008-0101-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
53 Barrera GJ, Portillo R, Mijares A, Rocafull MA, del Castillo JR, Thomas LE. Immunoglobulin A with protease activity secreted in human milk activates PAR-2 receptors, of intestinal epithelial cells HT-29, and promotes beta-defensin-2 expression. Immunol Lett 2009;123:52-9. [PMID: 19428552 DOI: 10.1016/j.imlet.2009.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]